Martingale Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Martingale Asset Management's EW Position: Q4 2020 in Review
Martingale Asset Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 44,506 shares — an estimated $3.55M sold.
Martingale Asset Management first reported a position in EW in Q3 2014 and held it in 11 quarters. The position peaked at $17.7M in Q1 2015. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.
- Martingale Asset Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
- Martingale Asset Management sold 44,506 Edwards Lifesciences shares in Q4 2020, an estimated $3.55M.
- Martingale Asset Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 11 quarters.
- Martingale Asset Management's Edwards Lifesciences position peaked at $17.7M in Q1 2015.
- 1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.
Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.